Restless Legs Syndrome Channel
Topics & Medications
Related Channels

Requip Dosing

Your healthcare provider will come up with Requip dosing guidelines based on what you are being treated for, other medications you may already be taking, and any other existing medical conditions. The typical dosing guidelines for Parkinson's disease range from 0.25 mg to 24 mg per day. Requip dosing guidelines for restless legs syndrome range from 0.25 mg to 4 mg per day.

Requip Dosing: An Introduction

The dose of Requip® (ropinirole hydrochloride) recommended by your healthcare provider will vary, depending on a number of factors, including:
  • The medical condition you are being treated for (Parkinson's disease or RLS)
  • Other medical conditions you may have
  • Other medications you may be currently taking.
As is always the case, do not adjust your dosage unless specifically instructed to by your healthcare provider. The dosing directions for Parkinson's disease and restless legs syndrome are very different. Make sure to follow your healthcare provider's directions carefully.

Requip Dosing for Parkinson's Disease

The recommended starting dose for people with Parkinson's disease is 0.25 mg, three times a day. Your healthcare provider may choose to increase the dose if symptoms continue or decrease the dose if Requip side effects occur. It may take several weeks to find the correct Requip dose for your particular situation.
Requip dosages of more than 24 mg per day have not been tested in Parkinson's disease research studies.
When it is time to stop your Requip, your healthcare provider will gradually decrease the dose over a week or two.
Know the Signs - Concussion Safety

Requip Medicine

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.